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The dependence of human immunodeficiency virus type 1 (HIV-1) on its NF-kB binding sites (kB sites) for
replication in transformed and primary T-cell targets was examined by infecting cells with HIV-1 reporter
viruses containing kB site enhancer mutations. Viral transcription was measured either with luciferase-
expressing HIV-1 that infects for a single round or by flow cytometric analyses with HIV-1 expressing placental
alkaline phosphatase (PLAP) or green-fluorescent protein (GFP). Both PLAP- and GFP-expressing viruses
spread from cell to cell and allowed analysis of viral gene expression patterns in single cells. Infection of a
panel of T-cell lines with different basal levels of NF-kB demonstrated a direct correlation between the amount
of constitutive nuclear NF-kB and the degree to which a wild-type virus outperformed kB site mutants. One
T-cell line with a constitutively high level of nuclear NF-kB, PM1, showed a 20-fold decrease in transcription
when its kB sites were mutated. In contrast, in a T-cell line with a low basal level of NF-kB, SupT1, mutation
of the kB site in the enhancer had no effect on viral transcription or growth rate. Phytohemagglutinin-activated
peripheral blood mononuclear cells showed a large dependence on the kB sites for optimal virus growth.
Viruses without marker genes corroborated the finding that mutations to the kB sites impair virus production
in cells with a high basal level of NF-kB. These data show that in T cells, HIV-1 can use NF-kB to enhance its
growth but the virus is clearly able to grow in its absence.
The transcription factor NF-kB is thought to play a major
role in the regulation of human immunodeficiency virus type 1
(HIV-1) gene expression (20). Originally characterized as a
transcription factor important for immunoglobulin k light-
chain gene transcription, NF-kB has since been more broadly
implicated in regulating many other immunomodulatory
genes, including those for interleukin 2 (IL-2), the IL-2 recep-
tor, tumor necrosis factor alpha (TNF-a), IL-6, granulocyte-
macrophage colony-stimulating factor, and the class II major
histocompatibility complex (3, 16). NF-kB is induced upon
activation of primary human T cells (13) and is also found at
high levels in cultured monocytes; these are the two major
targets of HIV-1 infection. Two tandem consensus binding
sites for NF-kB are highly conserved on virtually all isolates of
HIV-1, and single sites are found on HIV-2 and most isolates
of simian immunodeficiency virus. Numerous studies have ob-
served a correlation between activation of NF-kB and the
stimulation of transcription of long terminal repeat (LTR)
reporter constructs or of integrated proviral sequences in
chronically infected cell lines (8, 12, 21).
Earlier work used transient transfection of LTR-driven re-
porter constructs to dissect the functional cis elements impor-
tant for activation of HIV-1 transcription (11, 20, 23). Al-
though this approach has been fruitful in uncovering important
cis-acting elements, it fails to recapitulate many aspects of
normal viral transcriptional regulation because of several lim-
itations. First, transient transfection methods involve the in-
troduction of much higher copy numbers of LTR-containing
DNA to each cell than that seen during infection of cells.
Second, because transfected DNAs are not incorporated into
chromatin they may not be regulated in the same manner as
integrated retroviral promoters. Several recent studies suggest
that alterations of chromatin structure correlate with induction
of NF-kB and HIV-1 transcription (22, 28). Third, the process
of infection with HIV-1 may influence levels of NF-kB (2, 4,
25). Therefore, much of the previous work measuring the im-
portance of NF-kB outside the context of infection has ne-
glected virus-host interactions that may affect NF-kB levels
and function. Lastly, measurement of the effects of enhancer
mutation must be made during infection to assess the potential
effects of HIV-1 regulatory genes such as tat or nef on NF-kB-
directed transcription.
The few studies investigating the role of the cis elements in
the HIV-1 LTR on viral growth and replication have come to
conflicting conclusions regarding the importance of the kB
sites during infection of cells. Initial reports suggested that the
kB sites are largely dispensable for viral growth in cell culture
(15, 24). However, a more recent report suggests that there is
an absolute requirement for kB sites for replication in primary
cells (1). These disparate observations leave the issue of how
the kB elements function during viral growth unresolved.
To clarify the issue of how discrete LTR mutations change
viral transcription and growth properties of HIV-1 in human T
cells, we examined the question of the relative importance of
intact kB binding elements with more efficient virus production
and more quantitative virus analytic technology. Our experi-
ments avoid the use of prolonged virus cultivation to produce
mutant virus prior to measurement of its growth, as has been
done in previous viral growth studies (1, 15, 24). We achieve
this by producing high initial titers of HIV-1 by transient trans-
fection of 293 cells. Here we provide analyses of the effects of
a discrete enhancer mutation on the levels of viral gene ex-
pression during single-round infection and correlate such de-* Corresponding author.
5495
fects with gene expression in individual cells and the subse-
quent growth of HIV-1. We examine the effects of enhancer
mutations in primary peripheral blood mononuclear cells
(PBMC) and in T-cell lines with various levels of NF-kB bind-
ing activity and show that mutation of the enhancer can have a
dramatic effect or no effect, depending upon variations in the
basal levels of nuclear NF-kB found in a given target cell. We
conclude that NF-kB can play a central role in enhancing
HIV-1 growth, but we cannot show an absolute requirement
for this factor.
MATERIALS AND METHODS
Cells. SupT1 is a CD41 CD81 CD32 T-leukemic line isolated from a pleural
effusion of a non-Hodgkin’s lymphoma patient (27). Jurkat clone E6 is a CD41
CD31 T-leukemic line derived by limit dilution cloning over macrophages (29).
PM1, a derivative of HUT78, is a CD41 T-leukemic line that has been found to
support infection of a wide variety of primary and laboratory-adapted isolates of
HIV-1 (18). SupT1 from James Hoxie, Jurkat clone E6 from Arthur Weiss, and
PM1 from Paolo Lusso and Marvin Reitz were obtained from the AIDS Reagent
Repository. PBMC were purified twice by centrifugation over a Ficoll-Hypaque
(Pharmacia) gradient and incubated in RPMI medium containing 10% fetal calf
serum, either with or without 2 mg of phytohemagglutinin (PHA) per ml for 36
to 40 h prior to infection and maintained in medium containing 20 U of recom-
binant human IL-2 (Genzyme) per ml.
Electrophoretic mobility shift assays (EMSA). Nuclear extracts for EMSA
were prepared with a modification of the protocol of Dignam et al. (7, 17).
Briefly, 20 3 106 cells, treated with 20 ng of recombinant human TNF-a (Gen-
zyme) per ml or untreated, were washed once with ice-cold phosphate-buffered
saline, resuspended in ice-cold buffer A (10 mM N-2-hydroxyethylpiperazine-N9-
2-ethanesulfonic acid [HEPES, pH 7.9], 1.5 mM MgCl2, 10 mM KCl), and then
lysed by addition of an equal volume of buffer A containing 0.2% Nonidet P-40.
Nuclei were pelleted by low-speed centrifugation and resuspended in buffer C
(25% glycerol, 20 mM HEPES [pH 7.9], 1.5 mM MgCl2, 0.6 M KCl, 0.2 mM
EDTA, 0.5 mM phenylmethylsulfonyl fluoride, 0.5 mM dithiothreitol) with vig-
orous pipetting. Extracts were cleared by high-speed ultracentrifugation and
stored at 270°C. EMSA was performed as described previously (17), with a
hairpin consensus HIV-immunoglobulin k probe (10).
Viruses. Viruses were produced from molecular clone HXB-2D in proviral
vector R7 (9). PCR-mediated, site-directed mutagenesis was performed by am-
plifying a 772-bp fragment encompassing the 39 LTR region and subcloning the
recombinant fragment into the place of the 39 LTR via a unique XhoI site and a
recombinant AscI site engineered into the 39 end of the proviral sequence. The
primers used for PCR amplification were 59-GATGGGGTGGGAGCAGCAT
CT-39 and 59-ATGCTCTAGAGGCGCGCCAGAGTCACACAACAGACGG
GCA-39.
The resulting provirus contains a deletion of a portion of the sequence flanking
the 39 end of the provirus. LTR sequences were confirmed by dideoxy sequencing
(ABI Sequenator; Applied Biosystems). The HXB-DkB-alt provirus was made by
replacing the XhoI-SacI fragment containing the 39 HIV-1 LTR in proviral clone
R7 with a mutant LTR from proviral clone BH8 with site-directed mutations to
both kB sites. Construction of HXB-Luc (luciferase) and HXB-PLAP (placental
alkaline phosphatase have been described previously (5, 6). HXB-GFP (green-
fluorescent protein) was engineered in an analogous fashion to the luciferase-
and PLAP-expressing viruses, by using a modified allele of the Aequorea victoria
GFP from Clontech, Enhanced GFP. Enhanced GFP was PCR amplified and
cloned into unique NotI and XhoI sites in HXB-Luc. HXB virus that has not been
engineered to express marker genes does express a functional repaired nef open
reading frame. Virus was produced by calcium phosphate methods and harvested
at 48 h following transfection as previously described (5). Virus was quantitated
by p24 enzyme-linked immunosorbent assay (19) to normalize all infections to
equivalent antigenic input.
Luciferase assays and flow cytometry. Luciferase assays were performed as
described previously (6). Flow cytometry was performed on a FACScan (Becton
Dickinson) as previously described (5). A modified allele of GFP which has had
its coding sequence changed to allow optimal translation in mammalian cells was
obtained from Clontech and detected by FACScan on the FL1 channel, 530/30
nm.
Reverse transcriptase-mediated PCR of cultured HIV-1. Cell-free superna-
tants precleared of cellular debris by low-speed centrifugation were ultracentri-
fuged at 28,000 rpm (Beckman SW60.1) to pellet virions, and viral RNAs were
prepared with Tri-Reagent (Molecular Research Center) in accordance with the
manufacturer’s instructions. Random hexamer (for the U3 region) and oligo(dT)
(for the U5 region) primers were used to prime cDNA syntheses. The U3 and U5
regions were amplified with 26 cycles of PCR with native Pfu polymerase (Strate-
gene) from the viral cDNAs with the following sets of primers and subcloned into
pBluescript: U3, 59-GAT GGG GTG GGA GCA GCA TCT-39 and 59-TTT ATT
GAG GCT TAA GCA GTG-39; U5, 59-GGA ACC CAC TGC TTA AGC
CTC-39 and 59-CAT GGC GCG CCT GCT AGA GAT TTT CCA CA-39. No
amplification products were detected in control cDNA synthesis reactions that
did not include murine leukemia virus reverse transcriptase. Duplicate bacterial
colony lifts were created from bacterial transformations containing U3 region
PCR products from samples described in Results. Filters were hybridized with a
32P-radiolabelled oligonucleotide complementary to the wild-type (WT) kB site
(59-AAG GGA CTT TCC GCT GGG GAC-39) or to the mutated kB site
(59-CAA TCT ACT TTC CGC TGT CTA CT-39) in accordance with standard
methods (26). Sequence analysis was performed with a dideoxy terminator cycle
sequencing kit (Applied Biosystems) and an ABI Sequenator.
RESULTS
Determination of endogenous NF-kB activity in three T-cell
lines. We prepared nuclear extracts from three human T-lym-
phoblastoid cell lines routinely used to propagate HIV-1 in
tissue culture, SupT1, Jurkat clone E6, and PM1. EMSA were
used to determine both basal and TNF-a-activated levels of
NF-kB, and the three cell lines tested differed markedly. No
basal NF-kB activity was detected in SupT1, a small amount of
basal activity was found in Jurkat cells, and high basal activity
was observed in PM1 cells (Fig. 1, lanes 5, 3, and 1, respec-
tively). Constitutive activation of NF-kB in PM1 cells may be
due, in part, to a genetic mutation found in the parental cell
line HUT78 which created an activated form of the NFKB2
gene product (30). As might be expected, TNF treatment gave
the greatest relative increase in specific DNA binding activity
in SupT1 cells, an intermediate response in Jurkat cells, and
only a small increase in PM1 cells (Fig. 1, lanes 2, 4, and 6,
respectively).
Measurement of viral transcriptional activity in a single
round of infection. To measure the role of the HIV-1 kB sites
in viral growth in these human T cells, we employed an infec-
tious luciferase-expressing HIV-1 vector, HXB-Luc, which in-
fects cells efficiently for only a single round (6). To study the
FIG. 1. EMSA on nuclear extracts binding to kB site-containing DNA. Nu-
clear extracts were prepared from the indicated T-cell lines following a 30-min
treatment with TNF-a or no treatment.
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role of the kB sites, we selectively mutated both kB sites in the
39 U3 region of the proviral DNA, changing the initial GGG of
both kB sites to TCT, thus eliminating NF-kB binding to the
HIV-1 enhancer (14). While the 59 U3 region controls tran-
scription, only the 39 U3 region of the retrovirus is transcribed
into genomic viral RNA. This 39 U3 sequence is copied during
reverse transcription, providing the template for the 59 U3
region in progeny provirus. Therefore, transfection of a 39 U3
mutant proviral construct should yield predominantly proviral
progeny with two mutated LTRs. This strategy was used to
allow us to produce high-titer virus by transient transfection
with transcription directed by the 59 LTR so that WT and U3
mutant viruses can be generated with similar efficiencies. In
fact, transfection of mutant and WT HXB-2D proviral plas-
mids into 293 cells yielded similar levels of p24 from both
constructs (data not shown). This approach avoids the need to
amplify virus in cells prior to experimentation as has been the
case in previous studies.
Using the 293 cell supernatants for infection of T-cell lines,
we found differences between WT viruses (HXB-Luc-WT) and
mutant viruses (HXB-Luc-DkB) dependent upon the target
cells tested. These differences provide a measure for the de-
pendence of HIV-1 on kB sites in each cell type tested. In
SupT1, HXB-Luc-WT was less than twofold more active than
HXB-Luc-DkB (Fig. 2a). In PM1 cells, a much larger differ-
ence was observed: 20- to 30-fold greater activity from the WT
than from a DkB virus (Fig. 2c). In Jurkat cells, an intermedi-
ate three- to fivefold difference was found (Fig. 2b). The mag-
nitude of the difference between WT- and DkB-directed lucif-
erase activities correlated well with the basal level of DNA-
binding NF-kB in each case.
Treatment of HXB-Luc-infected cells with TNF-a resulted
in a large activation of luciferase activity in SupT1 cells, a
smaller induction in Jurkat cells, and small inhibition in PM1
cells (Fig. 2a to c). The inhibition of luciferase activity in PM1
cells was less prominent at earlier time points (data not shown)
and could be due to antiproliferative or other pleiotropic ef-
fects of TNF-a which occur following prolonged exposure to
the cytokine. The mutation of the NF-kB site completely ab-
rogated the ability of TNF-a to elicit activation in all T cells
tested, showing that in the intact virus, mutation of these sites
is sufficient to completely eliminate TNF-a activation of
HIV-1. This analysis shows that the relative dependence of the
HIV-1 LTR on NF-kB sites correlates well with basal levels of
NF-kB activity. A strong, inducible NF-kB activity can be ob-
served in SupT1 cells, yet they do not show dependence upon
NF-kB following infection. This provides strong indirect evi-
dence that the infection process itself does not activate NF-kB
activity in cell lines with low basal NF-kB activity.
Infection of PHA-stimulated PBMC was also performed
(Fig. 2d). Although the levels of luciferase activity from the
primary cells was lower than that of the T-cell lines tested, the
Luc activity was well over the background levels for both the
WT and mutant LTR luciferase-expressing viruses. The lower
activity in primary cells may, in part, be reflective of a smaller
fraction of total cells that actively replicate under such activa-
tion conditions. We found in independent experiments that
roughly 10% of the total PBMC actively incorporated bro-
modeoxyuridine following PHA activation at 24 h (data not
shown). The pattern of luciferase expression observed in the
activated cells most closely resembled that of PM1 cells. Thus,
activated PBMCs have high levels of NF-kB-dependent tran-
scription and also display inhibition by TNF-a treatment. The
cellular environment found in PHA-activated PBMC thus ap-
peared to be maximally activated for NF-kB in a manner which
functionally resembles that of PM1 cells.
Single-cell analysis of HIV-1 infection. To analyze on a sin-
gle-cell basis how mutations in the enhancer affect the virus’
ability to progress through its life cycle, we engineered the kB
mutant LTR and WT HIV-1 to carry genes for the cell surface
protein PLAP or for cytoplasmic GFP. In both constructs, the
marker gene is put in the place of the HIV-1 nef reading frame.
Although previous reports have suggested that Nef fusion pro-
teins may activate NF-kB, we have found no evidence for an
increase in NF-kB-dependent viral growth in the presence of
nef (3a). Staining for PLAP or GFP in conjunction with stain-
FIG. 2. Luciferase-expressing virus infection of SupT1, Jurkat, and PM1 cells and PBMC. Infected cells were stimulated with TNF-a at 48 h postinfection or left
unstimulated, and luciferase activity was measured at 72 h postinfection. Results are representative of three independent experiments with independent virus
preparations.
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ing for the viral receptor, CD4, allows discrimination between
the early and late phases of viral replication (5).
Shortly following infection with HXB-PLAP virus, cells in
the early phase of infection are marker gene positive yet still
retain cell surface CD4 (CD41 PLAP1). When the levels of
marker genes increase during the late phase of the viral life
cycle, Env protein is expressed, which down-modulates CD4
(CD42 PLAP1). Due to the absence of functional nef and vpu
in this HXB-2 molecular clone of HIV-1, Env is the only gene
product which can affect the levels of CD4 during this infec-
tion. Following infection of Jurkat cells with HXB-PLAP-WT
and HXB-PLAP-DkB, the two viruses infected similar num-
bers of cells (within twofold) based upon the percentage of
total cells that became PLAP positive after 3 days (Fig. 3a).
Notably, the cells infected with the mutant virus showed similar
levels of PLAP-associated fluorescence and also showed a sim-
ilar pattern of CD4 down modulation in PLAP-high cells, sug-
gesting that the level of viral transcription in these cells is
sufficient for the virus to progress into the late phase of viral
gene expression. However, over time we saw that the WT virus
spread to infect a greater fraction of the cell culture at a
significantly faster rate.
From fluorescence-activated cell sorter (FACS) plots like
those in Fig. 3a, growth curves were then plotted (Fig. 3b)
which illustrate the ability of the WT and mutant viruses to
infect and deplete CD4-positive Jurkat cells. The upper right
panel in Fig. 3b shows the rise and fall of cells exhibiting a
CD41 PLAP1 phenotype indicative of the early stages of in-
fection. The lower right panel in Fig. 3b shows the rise and fall
of cells exhibiting a CD42 PLAP1 phenotype indicative of the
late stages of infection. In all of the infections analyzed in this
manner, the peak in the number of CD41 PLAP1 cells pre-
cedes the peak in CD42 PLAP1 cells, illustrating a clear pro-
gression from early to late infection. In all cases, there is a
significant lag in the rise and fall of these infected populations
in the kB site-mutated viruses. Similar results were obtained
with the two different starting concentrations of virus used
(Fig. 3b). In Jurkat cells, a small percentage of what are ini-
tially CD42 cells resist infection and maintain a CD42 PLAP2
phenotype. Over time, these become the dominant cell type in
the culture (Fig. 3b, lower left panel), following the growth
inhibition and death of the virus-infected cells. We found that
the NF-kB mutant virus exhibited a 6- to 10-day delay in its
ability to deplete the entire culture of CD41 cells (Fig. 3b,
upper left panel).
We then tested GFP-expressing viruses in SupT1, Jurkat,
and PM1 cells (Fig. 4). Comparing the GFP results with the
PLAP results allowed us to determine whether the results of
single-cell analyses may be peculiar to a particular reporter
gene. Interestingly, with the three cell lines we saw a strong
correlation between the basal level of NF-kB and the effect of
kB site mutation on the rate of viral spread. In SupT1 cells,
which have low basal NF-kB activity, there was no observable
delay in the ability of HXB-GFP-DkB to spread compared with
HXB-GFP-WT (Fig. 4a). In Jurkat cells infected with GFP-
expressing viruses, we observed a growth delay caused by the
DkB construct consistent with the PLAP virus data shown
above (Fig. 4b). In PM1 cells, which have high basal NF-kB
activity, a more dramatic delay in the spread of HXB-GFP-
DkB was observed, consistent with the large 20-fold transcrip-
tional defect observed during HXB-Luc-DkB infection (Fig.
4c). At 9 days following infection of PM1 cells with HXB-GFP-
WT, virtually all of the cells had rapidly progressed to become
CD42 GFP1. At this same time point, only a small fraction of
the cells had been infected by the mutant virus. At day 12,
HXB-GFP-DkB did spread in PM1 cells to infect a significant
fraction of the cells; however, the average intensity of GFP
expression in cells with the highest GFP expression was almost
10-fold lower than that seen in cells infected with HXB-GFP-
WT. The lower level of GFP found in these CD42 GFP1 cells
suggests that in PM1 cells, the virus with a mutant enhancer
can produce a spreading infection but does so at a lower peak
level of viral gene expression. These studies illustrate a range
of NF-kB dependence for viral growth which depends upon the
basal NF-kB level in the target cell. Interestingly, despite a
significant growth lag in some cells, enhancer mutant HIV-1
was still able to exert cytopathic effects in all three CD41 T-cell
lines (data not shown).
Assessment of viral growth by p24 production. To correlate
our marker gene studies with virus production, we tested viral
constructs which did not contain marker genes to monitor the
rate of p24 production during viral infection. Again, growth
defects of the mutant virus correlated well with the basal level
of NF-kB found in the T-cell lines. No detectable difference in
the rate of p24 production was found in SupT1 cells (Fig. 5a).
Notably, SupT1 cells supported a highly cytopathic infection
which depleted cells rapidly, forming giant ballooning syncytia.
These syncytia were found equally in infections with both the
WT and mutant viruses (data not shown). In contrast, infection
of Jurkat cells with HXB-DkB showed a consistent lag in p24
production; the mutant required 3 to 4 more days to reach
similar levels of p24 than did the WT (Fig. 5b). Infection of
PM1 cells with mutant virus revealed the most prominent delay
in p24 production (Fig. 5c). Eight days after the infection of
PM1 cells, there was a more-than-100-fold difference in p24
production between the two viruses. At a later time point,
when the WT has already largely depleted the CD41 cells, the
mutant reaches a peak virus production roughly fourfold lower
than that of the WT.
We next examined the ability of PHA-activated PBMC to
support infection of WT or mutant virus. A marked growth lag
was observed in PBMC infected with HXB-DkB compared to
those infected with HXB-WT. Because previous reports have
shown a prominent defect in cells that are infected in a quies-
cent state and subsequently activated, we tested both cells
activated before infection (Fig. 5d) and cells activated follow-
ing infection (Fig. 5e). The delay in viral growth was observed
whether the cells were stimulated prior to infection or 24 h
following infection of quiescent PBMC. The peak titer of the
HXB-DkB virus was more than 10-fold lower than that of
HXB-WT whether cells were stimulated before infection (Fig.
5d) or 24 h following infection (Fig. 5e). However, in contrast
to previous reports (1), the mutant virus is still capable of
producing levels of virus 3 orders of magnitude above the
threshold of detection (Fig. 5d and 5e).
Analysis of LTR sequences arising during in vitro infec-
tions. The slowed growth kinetics of the DkB virus raise the
issue of whether reversions in the mutant virus may occur to
compensate for the low levels of transcription of DkB virus.
Such mutations would cause us to underestimate the functional
defect of the NF-kB mutations which we have observed by
growth curve analysis. In addition, because our methods of
mutant virus production involve transfection of proviral con-
structs containing a WT 59 LTR, we must monitor our exper-
iments for potential recombination between the 59 and 39
LTRs. If recombinant virus represented a significant fraction
of the input virus, this too could cause us to underestimate the
growth defect of the DkB virus. To investigate these possibil-
ities, we utilized an alternate variant of the enhancer mutant,
designated HXB-DkB-alt, a viral construct which contains
small differences in its 39 LTR in comparison with that of
HXB-WT (Fig. 6). These sequence differences between the 39
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FIG. 3. Time course of infection of Jurkat cells with HXB-PLAP-WT and HXB-PLAP-DkB viruses. (a) FACS plots of HXB-PLAP-WT (top row)- and
HXB-PLAP-DkB (second row)-infected Jurkat cells showing progression of infection at 3, 6, and 12 days following infection with 100 ng of input p24. The single plot
at the bottom is representative of samples stained from mock-infected cells for all time points. The x axis represents PLAP fluorescence, and the y axis represents CD4
fluorescence, both on logarithmic scales. The number in each corner of the plot represents the percentage of total gated cells that fall into that quadrant. FITC,
fluorescein isothiocyanate; PE, phycoerythrin. (b) Time course of HXB-PLAP infections graphing the percentage of total cells which fall into each of the quadrants
at sequential time points. Changes in uninfected CD41 PLAP2 cells from the upper left quadrant (upper left graph), CD41 PLAP1 cells from the upper right quadrant
(upper right graph), CD42 PLAP1 cells (lower right graph), and CD42 PLAP2 cells (lower left graph) are graphed versus time.
5499
FIG. 4. Infections of different T-cell lines with HXB-GFP-WT and HXB-GFP-DkB viruses. FACS plots of HXB-GFP-WT (top row)- and HXB-GFP-DkB (bottom
row)-infected SupT1 (a), Jurkat (b), and PM1 (c) cells showing progression of infection at 3, 6, 9, and 12 days postinfection. The x axis represents GFP fluorescence,
and the y axis represents CD4-associated fluorescence, both on logarithmic scales.
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LTRs allow us to distinguish between reversion events and
potential cross-contamination of virus during experimentation.
Additionally, the 59 and 39 LTRs of HXB-2D can also be
distinguished based upon sequence differences so that recom-
bination between the 59 and 39 LTRs can also be readily de-
tected.
HXB-DkB-alt produced a growth lag relative to HXB-WT
comparable to that observed in other experiments conducted
with completely isogenic viruses (compare Fig. 5f with d and
e). Viruses from two time points were isolated from the infec-
tion for sequence analysis. In addition, virus from transfected
supernatants was also tested for the presence of contaminating
WT virus in the input mutant virus preparation (see Materials
and Methods).
RNAs from the input virus and the virus collected at two
time points were subjected to reverse transcriptase-mediated
PCR and cloned into pBluescript. Subcloned LTRs were se-
quenced, and a few subclones from the HXB-DkB infections
were, in fact, found to contain small numbers of WT LTRs.
Examinations of these WT sequences determined that these
WT LTRs were largely identical to the 59 LTR of the proviral
HXB-2D molecular clone. Therefore, these are most likely to
FIG. 5. Analysis of growth of HXB-WT and HXB-DkB in SupT1 (a), Jurkat (b), and PM1 (c) cells, PHA-stimulated (stim) PBMC (d), unstimulated (unstim) PBMC
stimulated 24 h postinfection with PHA (e), and PBMC infected with HXB-DkB-alt or HXB-WT, which contain distinct 39 LTRs (f). The arrows indicate times when
viral sequence analysis was performed. Virus production, measured by p24 enzyme-linked immunosorbent assay, is shown on a logarithmic scale.
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have arisen from low levels of WT virus generated by recom-
bination during transfection (data not shown). To determine
the frequency of WT LTRs found at different time points,
oligonucleotide hybridization to WT or mutant kB site probes
was performed on the U3 cDNAs to determine the ratios of
WT to mutant LTR sequences found in all of the samples
(Table 1). Analysis of the input inoculum detected no WT
sequence in the input virus from a screen of 107 colonies. In
addition, no mutant sequence was found in the WT inoculum.
However, 6% of the WT sequence was found in mutant virus
infections at day 5, which increased to represent 25% of all
LTRs at day 11. A careful inspection of the U5 sequences of 18
day 11 clones and 6 day 5 clones did not reveal any repetitive
mutations which could be interpreted as second-site revertants
(data not shown). In conclusion, we found that although our
system initially produced less than 1% recombinant WT virus
during virus production by transfection, we did detect signifi-
cant levels of recombinant virus at late time points. However,
even at a later point, the majority (75%) of the virus still
contained mutant sequence points confirming that the mutant
virus is able to replicate and produce progeny.
DISCUSSION
This study clearly defines the relative importance of the kB
sites in the HIV-1 life cycle in human T cells. We have mea-
sured LTR function during infection with three independent
assays and made correlations with a biochemical measure of
NF-kB activity. When considered together, the single-round
luciferase assay, single-cell flow cytometric analyses, and virus
production analyses provide a coherent picture of how a cis-
acting promoter element is important in the HIV-1 life cycle. It
is clear that the PM1 cells that showed the largest effect when
mutating the kB sites by luciferase assay were also the only
cells to show a significant decrease in the peak level of GFP
expression on the single-cell level. This also correlates with the
largest growth delay and a decrease in peak titer for infections
with a mutant virus in these cells. Furthermore, these cells also
demonstrated the highest basal level of NF-kB activity.
By both luciferase assay and viral growth analysis, PBMC
appeared to behave most like PM1 cells in having the most
dramatic effects when mutating the enhancer element. This
similarity suggests that NF-kB plays an important role in highly
activated T cells, although it is unclear to what extent a PHA-
activated cell resembles an activated T cell in vivo. In other
cells, however, we found little effect of mutation of the en-
hancer. We found that in SupT1 cells, a T-cell line with little or
no basal NF-kB activity, there is no dependence upon these cis
elements for optimal viral replication or spread. This shows
that the HIV-1 LTR is not absolutely dependent on its kB sites
for substantial growth. In all of the assays, Jurkat cells consis-
tently displayed phenotypes intermediate between those of
SupT1 and PM1 cells, concordant with their intermediate lev-
els of basal NF-kB activity.
In contrast to previous studies, our analysis of viral growth in
different T-cell environments correlates NF-kB DNA binding
activity with the phenotypes that we observed and differs tech-
nically from previous studies in key ways. Use of a more robust
viral production method which employs transfection of 293
cells allowed us to produce mutant virus in large quantities
without the need to amplify them in other cells prior to infec-
tion. Our marker gene methods enabled us to look at the
effects of mutations in a single round of infection, as well as in
multiple rounds, and find confirmatory results between the
various assays. In one previous case, in which the investigators
found mutant virus completely growth deficient (1), it is likely
that the methods they used to generate virus were not sufficient
for detection of the lower kB mutant virus levels, which can be
as much as 100-fold lower than those of a WT virus. In agree-
ment with that study, we did observe a marked effect of en-
hancer mutation in PBMC; however, in contrast to their study,
we clearly showed that an enhancer mutant can grow to 3
orders of magnitude above the limit of detection of our p24
assay. In earlier studies, in which little or no difference was
ascribed to the viruses lacking kB sites, it is possible that the
smaller differences observed could be due to selection of viral
variants during the production of viral stocks prior to experi-
mentation or, perhaps, to differences in the level of kB activa-
tion achieved by variations in PHA or IL-2 treatment.
Our sequence analysis did reveal that one shortcoming of
our methods was the generation of WT recombinants at low
levels during mutant virus production. These contaminants
were detectable following multiple infection cycles. However,
FIG. 6. Sequences of 59 and 39 LTRs of proviral constructs used for infections. The 59 LTRs of all of the constructs were identical. In Fig. 2 to 5e, the 39 LTRs used
are completely isogenic except for the kB sites. The DkB-alt LTR used especially for sequence analysis in Fig. 5f is indicated at the bottom. Sequence analyses of the
virus allows discrimination between cross-contamination, recombination, and reversion mutations. LTR sequence differences between DkB and DkB-alt extend beyond
the 200-bp region designated here, into the 59 nef sequence.
TABLE 1. Oligonucleotide hybridization analysis of viral U3
sequences cloned at different times of infectiona
Virus
DkB infection WT infection
Mutb WTb % WTc Mutb WTb % WTc
Input 107 0 0 0 160 100
Day 5 108 7 6 0 11 100
Day 11 219 73 25 0 137 100
a As shown in Fig. 5f.
b Values are numbers of individual bacterial colonies hybridizing to mutant
(Mut) or WT oligonucleotides as described in Materials and Methods.
c No. of WT colonies 4 (no. of mutant colonies 1 no. of WT colonies) 3
100%.
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the hybridization analysis confirmed that the preponderance of
virus was mutant throughout the period of time during which
we studied virus growth. This suggests that the mutant virus
could, indeed, replicate to a significant level. Because the rep-
lication of HXB-DkB could be readily detected in primary
cells, our data do not support the hypothesis that the activity of
Tat in primary cells is fundamentally dependent upon NF-kB
sites (1).
Because recombination was detected in the PBMC experi-
ment, experiments involving HXB-PLAP and HXB-GFP in-
fection of Jurkat or PM1 cells should provide a conservative
estimate of the differential between the WT and DkB viruses.
Consequently, the dependence on kB sites is possibly larger
than that shown by PLAP staining of cells. However, we cor-
roborated our results with single-cycle infections with lucif-
erase-encoding viruses that should be less affected by recom-
bination. These experiments confirm the disposition of the
enhancer mutants to transcribe HIV RNA at decreased levels
consistently in proportion to the levels of basal NF-kB. The
especially low level of transcription by HXB-Luc-DkB in PM1
cells could be suggestive of a global inhibitory effect on non-
kB-dependent transcription or a relative absence of other fac-
tors, e.g., Sp1, that may act to promote HIV transcription even
in the absence of NF-kB. In a similar vein, in SupT1 cells,
perhaps levels of these non-NF-kB HIV activators are high,
allowing robust replication in the absence of basal NF-kB.
Importantly, in both transformed T-cell lines and primary
cells, mutant virus was eventually able to achieve levels of gene
expression sufficient to allow virus production and spread to
neighboring cells. Single-cell analysis of infection by HXB-
PLAP-DkB or HXB-GFP-DkB suggests that the enhancer mu-
tation does not significantly impede the progression of virus
from early to late stages of infection. Especially early in the
infections, very similar levels of cells were initially targeted and
these contained similar ratios of cells in early (CD4 high) or
late (CD4 low) stages of infection. Flow cytometric analyses of
SupT1 cells further suggest that there is no absolute require-
ment for the NF-kB sites in cell lines and that other cellular
factors can promote viral transcription even in their absence.
Our report shows that the enhancer plays an important role
by increasing the level of virus production from each cell.
While mutant virus is capable of infecting cells to completion
and depleting CD4-positive cells, the peak p24 titers which
arise from WT virus can be 100-fold higher when the virus
contains intact NF-kB binding elements. When p24 values
were measured as a percentage of infected, PLAP1 Jurkat cells
observed by flow cytometric analyses, we found that the WT
virus produced severalfold more p24 per infected cell, suggest-
ing that the burst size of WT viruses is larger than that of the
enhancer mutant (data not shown). From these results, one
might predict that infection of individuals with DkB virus might
give rise to decreased viral loads and a slower disease course.
Interestingly, a recent report describes several viral isolates
from a single patient which are pathogenic despite containing
deletions of the NF-kB binding sites (31). While the patient
was initially characterized as belonging to a long-term survivor
cohort, he later progressed to AIDS. The virus isolated from
this patient, described by Zhang et al. (31), was also found to
have a duplication of a putative TCF-1 site in the U3 region.
We were therefore interested in identifying potential second-
site reversions in mutant virus from our own experiments
which might complement its slow-growth phenotype in vitro.
However, we failed to find any recurring mutations which ap-
peared over time. Nonetheless, it is interesting to speculate
that such compensatory mutations could occur in vivo. In the
studies of Zhang et al. (31), the LTRs were characterized with
luciferase reporter viruses and found to have basal transcrip-
tional rates only a fewfold lower than that found in WT virus,
in contrast to the 20-fold difference which we observe with a
discrete mutation of kB binding alone, suggesting that the
TCF-1 repeat may compensate for the lack of NF-kB sites in
this unique in vivo case.
From this study, a rationale for the extraordinary sequence
conservation of these sites in vivo becomes evident. During
virus growth in activated PBMC, an intact enhancer element
appears to contribute to an earlier and higher peak titer of
HIV-1. The finding that a tiny contaminating fraction of WT
virus in a DkB infection can achieve 25% of the total by the end
of an infection is a testimony to the competitive advantage of
a virus with an intact enhancer. It is clear from our studies that
activated, primary CD41 human lymphocytes provide a tran-
scriptional environment that heavily utilizes and provides sig-
nificant selective pressure to maintain functional kB sites.
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